Recent years have witnessed a surge of interest in <i>VMA21</i>, with the identification of novel mutations causing a congenital disorder of glycosylation (CDG) with liver affection, and its potent implication in cancer predisposition. This evidence concerns the gene VMA21 and congenital disorder of glycosylation.